These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4953989)

  • 1. The repository antimalarial activities of 4,4'-diacetylaminodiphenylsulfone and cycloguanil pamoate (Cl-501) in monkeys relative to local release following parenteral administration.
    Thompson PE; Waitz JA; Olszewski B
    J Parasitol; 1965 Jun; 51(3):345-9. PubMed ID: 4953989
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary studies on the anti-malarial activity of SDDS (2-sulfamoyl-4, 4'-diaminodiphenylsulfone) against Plasmodium berghei and Plasmodium gallinaceum.
    Ishii A; Sasa M; Chinzei H; Oshima S; Tanaka H
    Jpn J Exp Med; 1967 Aug; 37(4):301-21. PubMed ID: 5301401
    [No Abstract]   [Full Text] [Related]  

  • 3. LABORATORY STUDIES ON THE REPOSITORY ANTIMALARIAL ACTIVITY OF 4,4'-DIACETYLAMINODIPHENYLSULFONE, ALONE AND MIXED WITH CYCLOGUANIL PAMOATE (CI-501).
    THOMPSON PE; OLSZEWSKI B; WAITZ JA
    Am J Trop Med Hyg; 1965 May; 14():343-53. PubMed ID: 14292737
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimalarial studies on 4,4-diaminodiphenyl sulfone (DDS) and repository sulfones in experimental animals.
    Thompson PE
    Int J Lepr Other Mycobact Dis; 1967; 35(4):605-15. PubMed ID: 5626306
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of chlorovinyl sulfones as structural analogs of chalcones and their antiplasmodial activities.
    Dominguez JN; Leon C; Rodrigues J; Gamboa de Dominguez N; Gut J; Rosenthal PJ
    Eur J Med Chem; 2009 Apr; 44(4):1457-62. PubMed ID: 19036479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CI-564, A 1:1 mixture of cycloguanil pamoate (CI-501) and 4,4'-diacetylaminodiphenylsulfone (CI-556), against multiresistant falciparum malarias.
    Chin W; Contacos PG; Coatney GR; Jeter MH; Alpert E
    Am J Trop Med Hyg; 1967 Sep; 16(5):580-4. PubMed ID: 4861322
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening of Coptis teeta Wall. for antimalarial effect: a preliminary report.
    Sharma SK; Satyanarayana S; Yadav RN; Dutta LP
    Indian J Malariol; 1993 Sep; 30(3):179-81. PubMed ID: 8131885
    [No Abstract]   [Full Text] [Related]  

  • 8. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
    Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
    Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial activity of inhibitors of ADP-ribosyl transferase against Plasmodium yoelii infection in mice. 1. Preliminary data.
    Okolie EE; Adewunmi AI; Enwonwu CO
    Acta Trop; 1982 Sep; 39(3):285-7. PubMed ID: 6128898
    [No Abstract]   [Full Text] [Related]  

  • 10. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug resistance of Plasmodium and rational application of antimalarials].
    Liu DQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Oct; 23(5 Suppl):355-61. PubMed ID: 16562468
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting, repository antimalarial agents. Duration of protection in mice and monkeys following administration of pyrimethamine pamoate.
    Werbel LM; Jacobs RL; Steinkampf RW; Worth DF
    Am J Trop Med Hyg; 1984 Jul; 33(4):526-33. PubMed ID: 6236702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The origins of antimalarial drug resistance.
    Hastings IM
    Trends Parasitol; 2004 Nov; 20(11):512-8. PubMed ID: 15471702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current antimalarial drugs recommended by the World Health Organization for the treatment and prevention of malaria].
    Baranova AM
    Med Parazitol (Mosk); 2007; (3):56-9. PubMed ID: 17912843
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
    Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
    Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of some adamantane-based synthetic trioxanes against Plasmodium knowlesi in rhesus monkeys.
    Tripathi R; Mishra D; Rizvi A; Singh C
    Life Sci; 2007 Nov; 81(21-22):1544-8. PubMed ID: 17976659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary of recent abstracts. 3. Malaria.
    Field JW
    Trop Dis Bull; 1971 Apr; 68(4):393-411. PubMed ID: 4996942
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of mefloquine as an antimalarial].
    Bull World Health Organ; 1983; 61(3):401-11. PubMed ID: 6411373
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel molecular targets for antimalarial drug development.
    Sahu NK; Sahu S; Kohli DV
    Chem Biol Drug Des; 2008 Apr; 71(4):287-97. PubMed ID: 18298458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.